HRT myths vs facts: breast cancer, dementia, and the WHI fallout

Early Women's Health Initiative findings in 2002 sharply changed public discussion of hormone therapy. The trial studied specific regimens in particular populations, so its results should be read by regimen, age, timing, duration, and outcome rather than as one universal estimate. Current guidance is more specific about both benefit and risk.

The Women's Health Initiative tested specific hormone regimens in postmenopausal women across a broad age range. Its findings do not give every patient the same estimate. Current guidance distinguishes estrogen-only from combined therapy, systemic from local treatment, and earlier from later initiation.

Myth: Every hormone-therapy regimen carries the same breast-cancer risk. Fact: ACOG says combined therapy is associated with a small increased breast-cancer risk, while regimen, duration, age, timing, and personal history affect the overall benefit-risk discussion. ⁴

The accurate answer is specific rather than absolute. Combined systemic therapy, estrogen-only therapy, and low-dose local vaginal therapy are not interchangeable. Ask which product, route, duration, outcome, and baseline risk a number describes. ^{2, 4}

A relative-risk change can sound large while the absolute change is small. Ask for both the relative and absolute numbers, the population studied, and whether the same regimen and route apply to the decision in front of you.

On February 12, 2026, FDA approved changes for six menopausal hormone-therapy products, removing cardiovascular-disease, breast-cancer and probable-dementia risk statements from their boxed warnings. This did not remove all risk information or make every product suitable for everyone. Systemic estrogen-alone products retain the endometrial-cancer boxed warning. Review the specific label with your clinician. ¹

Custom-compounded hormones are not FDA-approved products. The Menopause Society says compounded bioidentical hormone therapy presents safety concerns and recommends government-approved formulations for almost all women. ‘Natural’ does not establish lower risk. ²

When a topic carries this much old fear, the provider you choose matters as much as the treatment. The right standard is simple to name. A good women's health provider reads your actual history, shows you both columns honestly, and does not lean on a 20-year-old headline to make your decision for you.

The fear was loud. The facts are quieter and more specific. You deserve a decision built on the current evidence and your own history, not a headline from two decades ago.